Page last updated: 2024-10-25

deferoxamine and Hypersensitivity, Type III

deferoxamine has been researched along with Hypersensitivity, Type III in 2 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fligiel, SE1
Ward, PA2
Johnson, KJ2
Till, GO1
Kunkel, RG1
Wilson, BS1

Other Studies

2 other studies available for deferoxamine and Hypersensitivity, Type III

ArticleYear
Evidence for a role of hydroxyl radical in immune-complex-induced vasculitis.
    The American journal of pathology, 1984, Volume: 115, Issue:3

    Topics: Animals; Apoproteins; Arthus Reaction; Chlorides; Deferoxamine; Dimethyl Sulfoxide; Drug Evaluation,

1984
Mediation of IgA induced lung injury in the rat. Role of macrophages and reactive oxygen products.
    Laboratory investigation; a journal of technical methods and pathology, 1986, Volume: 54, Issue:5

    Topics: Animals; Catalase; Deferoxamine; Dimethyl Sulfoxide; Dinitrophenols; Free Radicals; Haptens; Immune

1986